SE421424B - Analogiforfarande for framstellning av lysergsyraamider - Google Patents
Analogiforfarande for framstellning av lysergsyraamiderInfo
- Publication number
- SE421424B SE421424B SE7301353A SE7301353A SE421424B SE 421424 B SE421424 B SE 421424B SE 7301353 A SE7301353 A SE 7301353A SE 7301353 A SE7301353 A SE 7301353A SE 421424 B SE421424 B SE 421424B
- Authority
- SE
- Sweden
- Prior art keywords
- amamids
- preparation
- analogy procedure
- lyric acid
- lyric
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
- C07D457/08—Lysergic acid amides in which the amide nitrogen is a member of a heterocyclic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUGO001187 HU163546B (enrdf_load_stackoverflow) | 1972-02-04 | 1972-02-04 | |
HUGO001186 HU164051B (enrdf_load_stackoverflow) | 1972-02-04 | 1972-02-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE421424B true SE421424B (sv) | 1981-12-21 |
Family
ID=26318474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7301353A SE421424B (sv) | 1972-02-04 | 1973-01-31 | Analogiforfarande for framstellning av lysergsyraamider |
Country Status (20)
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU169073B (enrdf_load_stackoverflow) * | 1974-05-28 | 1976-09-28 | ||
HU168914B (enrdf_load_stackoverflow) * | 1974-07-30 | 1976-08-28 | ||
HU172649B (hu) * | 1975-04-24 | 1978-11-28 | Gyogyszerkutato Intezet | Sposob poluchenija novykh biologicheski aktivnykh lizergamidov |
DE2802023A1 (de) * | 1977-01-28 | 1978-08-03 | Sandoz Ag | Neue ergotderivate, ihre herstellung und verwendung |
JPH0438472U (enrdf_load_stackoverflow) * | 1990-07-31 | 1992-03-31 | ||
IT1260156B (it) * | 1992-08-03 | 1996-03-28 | Fidia Spa | Derivati dell'acido neuraminico |
WO2012177962A1 (en) * | 2011-06-23 | 2012-12-27 | Map Pharmaceuticals, Inc. | Novel fluoroergoline analogs |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH475252A (de) * | 1966-02-08 | 1969-07-15 | Sandoz Ag | Verfahren zur Herstellung neuer Lysergsäure-Derivate |
AT291446B (de) * | 1968-11-22 | 1971-07-12 | Richter Gedeon Vegyeszet | Verfahren zur Herstellung von neuen Apovincaminsäureamiden |
-
1973
- 1973-01-29 IL IL41409A patent/IL41409A/en unknown
- 1973-01-31 SE SE7301353A patent/SE421424B/xx unknown
- 1973-01-31 NL NLAANVRAGE7301369,A patent/NL178256C/xx not_active IP Right Cessation
- 1973-01-31 DK DK51373AA patent/DK141531B/da not_active IP Right Cessation
- 1973-02-01 EG EG41/73A patent/EG10823A/xx active
- 1973-02-01 FI FI303/73A patent/FI54118C/fi active
- 1973-02-01 AU AU51633/73A patent/AU475943B2/en not_active Expired
- 1973-02-02 CS CS73816A patent/CS191212B2/cs unknown
- 1973-02-02 YU YU0266/73A patent/YU36730B/xx unknown
- 1973-02-02 BE BE794888D patent/BE794888A/xx not_active IP Right Cessation
- 1973-02-02 NO NO430/73A patent/NO133670C/no unknown
- 1973-02-02 CA CA162,796A patent/CA994342A/en not_active Expired
- 1973-02-02 DD DD168642A patent/DD104299A5/xx unknown
- 1973-02-02 SU SU1880877A patent/SU468419A3/ru active
- 1973-02-02 GB GB522073A patent/GB1401155A/en not_active Expired
- 1973-02-02 CH CH152173A patent/CH589079A5/xx not_active IP Right Cessation
- 1973-02-02 FR FR7303737A patent/FR2190440B1/fr not_active Expired
- 1973-02-03 BG BG022616A patent/BG22832A3/xx unknown
- 1973-02-05 JP JP48013871A patent/JPS5221516B2/ja not_active Expired
- 1973-02-05 DE DE2305514A patent/DE2305514A1/de not_active Ceased
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE407579B (sv) | Forfarande for framstellning av n-fosfonometylglycin | |
SE398229B (sv) | Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat | |
SE417099B (sv) | Forfarande for framstellning av o-substituerade 7beta-amino-3-cefem-3-ol-4-karboxylsyraforeningar | |
NO140731C (no) | Fremgangsmaate for fremstilling av dimetyleter | |
SE395149B (sv) | Forfarande for framstellning av dibenso-tiepinylpiperazinderivat | |
SE7700442L (sv) | Forfarande for framstellning av 6-aminopenicillansyra | |
SE386892B (sv) | Forfarande for framstellning av oxaminoforeningar | |
SE401676B (sv) | Forfarande for framstellning av dibensofuranderivat | |
SE385698B (sv) | Forfarande for framstellning av kinolinettiksyraderivat | |
SE382053B (sv) | Forfarande for framstellning av bifenylylalkanoylaminopyridiner | |
SE392609B (sv) | Forfarande for framstellning av metanhaltiga gaser | |
SE383151B (sv) | Forfarande for framstellning av 1-hydroxi-2-pyridoner | |
SE399708B (sv) | Forfarande for framstellning av tioxanton-2-karboxylsyraderivat | |
SE402009B (sv) | Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat | |
SE421424B (sv) | Analogiforfarande for framstellning av lysergsyraamider | |
SE380272B (sv) | Forfarande for framstellning av n-fosfonmetylglycin | |
SE393111B (sv) | Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin | |
FI56830B (fi) | Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider | |
SE415355B (sv) | Forfarande for framstellning av fosfonotioureider | |
SE393808B (sv) | Forfarande for framstellning av isomaltit | |
SE391717B (sv) | Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner | |
NO140736C (no) | Fremgangsmaate til fremstilling av poly-alfa-oksyakrylsyre | |
NO136750C (no) | Fremgangsm}te for fremstilling av indanderivater | |
NO142307C (no) | Fremgangsmaate ved fremstilling av pregnansyrederivater | |
NO139890C (no) | Fremgangsmaate ved fremstilling av n5 -methyltetrahydrohomofolinsyre |